6-MAPB
![]() | |
| Systematic (IUPAC) name | |
|---|---|
|
1-(benzofuran-6-yl)-N-methylpropan-2-amine | |
| Clinical data | |
| Legal status | |
| Legal status |
|
| Identifiers | |
| CAS Number | 1354631-79-0 |
| ChemSpider | 32078890 |
| Chemical data | |
| Formula | C12H15NO |
| Molar mass | 189.25 |
| |
| |
6-MAPB (1-(benzofuran-6-yl)-N-methylpropan-2-amine) is a psychedelic and entactogenic drug which is structurally related to 6-APB and MDMA. It is not known to have been widely sold as a "designer drug" but has been detected in analytical samples taken from individuals hospitalised after using drug combinations that included other benzofuran derivatives. 6-MAPB was banned in the UK in June 2013, along with 9 other related compounds which were thought to produce similar effects.[1]
See also
References
- ↑ "Temporary class drug order report on 5-6APB and NBOMe compounds". UK Home Office. 4 Jun 2013. Retrieved 2013-07-10.
This article is issued from Wikipedia - version of the Saturday, April 02, 2016. The text is available under the Creative Commons Attribution/Share Alike but additional terms may apply for the media files.
